NKCC2 Antibodies

Santa Cruz Biotechnology delivers a wide array of NKCC2 monoclonal antibodies for research focused on understanding sodium-potassium-chloride cotransporter 2 (NKCC2) in various physiological processes. NKCC2 monoclonal antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NKCC2 is crucial for maintaining electrolyte balance and regulating fluid homeostasis in the kidneys. NKCC2 plays a significant role in the reabsorption of sodium, potassium, and chloride ions, which is essential for proper kidney function and blood pressure regulation. Dysregulation of NKCC2 has been implicated in various renal disorders and hypertension, making it an important target for therapeutic intervention. Research utilizing NKCC2 monoclonal antibodies enables detailed investigation of cellular mechanisms and pathways involved in kidney function. Understanding NKCC2 expression and activity patterns provides critical information about renal physiology and disease progression. NKCC2 research supported by Santa Cruz Biotechnology monoclonal antibodies continues to advance scientific understanding of kidney disorders and potential therapeutic approaches.